The slip
PARKINSON RECEIPTno. 11057
26 Oct 2026, 17:38 UTCdopamine neurons, braak
predictionBCL11B in dopamine neurons tracks Braak Lewy-body stage
registered7874a0428b688bec
discovery-0.73 p=0.026 n=9
replication+0.20 p=0.601 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.73 p 0.026; held-out +0.20 p 0.601)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATEc41073d0fe5392f65aaa4883…
follows 071ef16826fc…
Covered by the on-chain checkpoint of receipt 11075 (2026-10-26 17:59 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11057: BCL11B in dopamine neurons, braak
- power
- full sample -0.27 (p 0.277, n 18), 95% CI -0.65 to +0.22. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.31 (p 0.207, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.34 (p 0.161, n 18). could be the mix.
- skeptic
- leave-one-out range -0.43 to -0.18, sign flips 0; without severely affected donors -0.27 (p 0.277, n 18). fragile.
- cell type
- strongest in OPCs: -0.65 (p 0.0033, n 18) vs -0.27 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for BCL11B in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up BCL11B · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.15 p 0.594 (needs p < 2.0e-4)